TVM Capital Life Science
Investor profile
TVM Capital Life Science has backed 3 European tech companies across 3 funding rounds between 2017 and 2024, joining rounds totalling €59M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2017–2024
8 yrs
Total round €
€59M
sum of rounds joined
Deals by year
distinct rounds / yearTVM Capital Life Science — deals by year — interactive chart.
Data table
| TVM Capital Life Science — deals by year | |
|---|---|
| 2017 | 1 |
| 2024 | 2 |
Top sectors
by dealsTVM Capital Life Science — top sectors — interactive chart.
Data table
| TVM Capital Life Science — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsTVM Capital Life Science — stages — interactive chart.
Data table
| TVM Capital Life Science — stages | |
|---|---|
| Other | 1 |
| Series A | 1 |
| Series C | 1 |
Countries
by dealsTVM Capital Life Science — countries — interactive chart.
Data table
| TVM Capital Life Science — countries | |
|---|---|
| Germany | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Centogene | Germany | 1 | €25M |
| Smart Reporting | Germany | 1 | €23M |
| myo | Germany | 1 | €11M |